Wearable Sensors to Study Low Blood Sugar in Type 1 Diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study uses a wearable sensor (like a smartwatch) to track your body's signals when blood sugar drops low. The goal is to understand low blood sugar patterns better, which may help improve prevention and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have type 1 diabetes for more than 2 years.
- You must use an insulin pump or multiple daily injections.
- You must be able to wear a continuous glucose monitor (CGM).
- Your most recent A1c (average blood sugar) must be between 7% and 10%.
- You must not be pregnant or breastfeeding, and agree to use birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new continuous glucose monitor (CGM) designed to help manage blood sugar levels. You will wear the device for 15 days and attend three clinic visits to see how well it works.
This study tests a wearable device that may measure insulin levels without needing blood draws. If you have type 1 diabetes, you might help researchers learn if this new sensor works for daily monitoring.
This trial studies how well a continuous glucose monitor (a sensor that tracks glucose) works for managing blood sugar in adults with type 1 or type 2 diabetes. You may need to wear sensors and have glucose levels adjusted during clinic visits to test safety and effectiveness.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
This study watches blood sugar changes over time in people who do not yet have diabetes but have test results that suggest risk for type 1 diabetes. The goal is to see whether “blood sugar variability” can predict when high or low blood sugar may happen, even before symptoms.
This study tests a device that measures both glucose and ketone levels continuously. It may help people with type 1 diabetes better manage their condition by providing real-time data.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.